Literature DB >> 18613023

The molecular weight cut-off of microcapsules is determined by the reaction between alginate and polylysine.

G M Vandenbossche1, P Van Oostveldt, J Demeester, J P Remon.   

Abstract

Mammalian cells encapsulated in alginate-polylysine microcapsules are used as artificial organs in cancer research and in biotechnology. These applications require microcapsules with a reproducible mol. wt. cut-off. The high cost of the polycation, polylysine, requires an efficient preparation procedure. This article shows that the overall reported contact time of 5 minutes at ambient conditions should be increased several times in order to reach a maximal binding between the calcium alginate beads and 0.1% (w/v) polylysine solutions. An increase of the polylysine concentration from 0.0125% to 0.8% (w/v) resulted in a faster maximal binding, but the amount of polylysine bound increased also. Immersion of calcium alginate beads with a diameter of 750 mum, prepared from 1 mL alginate, in 30 mL of a 0.8% (w/v) polylysine solution, resulted in a polylysine spill of more than 89%. The time required to reach a maximal binding was related to the reaction temperature. The interaction zone between calcium alginate beads and fluorescein isothiocyanate-labeled polylysine solutions was visualized with a confocal laser scanning microscope as a function of time. Microcapsules, prepared at 40 degrees C with 0.1% (w/v) polylysine solutions with mol. wts. between 12 and 249.2 kD, were permeable for fluorescein isothiocyanate-labeled dextran, mol. wt. 4.7, but not for 40.5 kD. Higher polylysine concentrations resulted in a membrane with a mol. wt. cut-off lower than 4.7 kD. (c) 1993 John Wiley & Sons, Inc.

Entities:  

Year:  1993        PMID: 18613023     DOI: 10.1002/bit.260420316

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  9 in total

Review 1.  Stem cell microencapsulation for phenotypic control, bioprocessing, and transplantation.

Authors:  Jenna L Wilson; Todd C McDevitt
Journal:  Biotechnol Bioeng       Date:  2013-01-17       Impact factor: 4.530

Review 2.  Immunoisolation to prevent tissue graft rejection: Current knowledge and future use.

Authors:  Anu David; James Day; Ariella Shikanov
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-02

3.  Morphology and metabolism of Ba-alginate encapsulated hepatocytes with galactosylated poly(allyl amine) and poly(vinyl alcohol) as extracellular matrices.

Authors:  Inn-Kyu Kang; Jong-Sik Moon; Hong Myeong Jeon; Wan Meng; Yang Il Kim; Yoon Jin Hwang; Sukyoung Kim
Journal:  J Mater Sci Mater Med       Date:  2005-06       Impact factor: 3.896

4.  Identification of IL-1β and LPS as optimal activators of monolayer and alginate-encapsulated mesenchymal stromal cell immunomodulation using design of experiments and statistical methods.

Authors:  Andrea Gray; Timothy Maguire; Rene Schloss; Martin L Yarmush
Journal:  Biotechnol Prog       Date:  2015-05-28

5.  The Alginate Immobilization of Metabolic Enzymes Platform Retrofits an Estrogen Receptor Transactivation Assay With Metabolic Competence.

Authors:  Chad Deisenroth; Danica E DeGroot; Todd Zurlinden; Andrew Eicher; James McCord; Mi-Young Lee; Paul Carmichael; Russell S Thomas
Journal:  Toxicol Sci       Date:  2020-12-01       Impact factor: 4.849

6.  Reduction of the inflammatory responses against alginate-poly-L-lysine microcapsules by anti-biofouling surfaces of PEG-b-PLL diblock copolymers.

Authors:  Milica Spasojevic; Genaro A Paredes-Juarez; Joop Vorenkamp; Bart J de Haan; Arend Jan Schouten; Paul de Vos
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

7.  Considerations in binding diblock copolymers on hydrophilic alginate beads for providing an immunoprotective membrane.

Authors:  Milica Spasojevic; Swapnil Bhujbal; Genaro Paredes; Bart J de Haan; Arend J Schouten; Paul de Vos
Journal:  J Biomed Mater Res A       Date:  2013-07-24       Impact factor: 4.396

8.  Impact of alginate composition: from bead mechanical properties to encapsulated HepG2/C3A cell activities for in vivo implantation.

Authors:  Stephanie H Capone; Murielle Dufresne; Mathias Rechel; Marie-José Fleury; Anne-Virginie Salsac; Patrick Paullier; Martine Daujat-Chavanieu; Cecile Legallais
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

Review 9.  Islet transplantation: the quest for an ideal source.

Authors:  Nidal A Younes; Jean-Manuel Nothias; Marc R Garfinkel
Journal:  Ann Saudi Med       Date:  2008 Sep-Oct       Impact factor: 1.526

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.